TMCnet News
NeuroMetrix Reports High Level of Media Coverage for Quell in First QuarterNeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative Quell® Wearable Pain Relief Technology™. Highlights include:
About Quell Wearable Pain Relief Technology Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented technology to provide widespread pain relief. In a recent clinical study, Quell improved chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online at www.QuellRelief.com. About NeuroMetrix NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT (News - Alert) Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com. View source version on businesswire.com: http://www.businesswire.com/news/home/20160408005547/en/ |